By Yuval Marcus and Jordan Garner, Experienced IP attorney specializing in litigating trademark, patent and copyright cases and IP due diligence Intellectual property has become an increasingly important driver of M&A transactions and investments in technology companies. IP is particularly significant in transactions involving medical, life-science and biotechnology companies, which rely…
Subscribe Membership Required
You must be a Subscribe member to access this content.
Already a member? Log in here
